Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Transitional Cell Carcinoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Transitional Cell Neoplasm
Transitional Cell Carcinoma

Histology

Transitional Cell Carcinoma

CI-CAN-00001613Explore in graph →

253 active trials5 approved drugs22 evidence items

NCIt: C2930
DOID: 2671
MeSH: D002295

Overview
Statistics
Survival
Genomics24
Variants & evidence22
Drugs13
Trials734
Research
Rankings
Sources & provenance

Data completeness5 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A carcinoma composed of malignant urothelial cells or cells that resemble malignant urothelial cells. This category includes urothelial carcinomas, female reproductive system transitional cell carcinomas, and primary peritoneal transitional cell carcinomas.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

CarcinomaCancer Family
Transitional Cell NeoplasmCancer Family

Children (4)

ncit

Female Reproductive System Transitional Cell Carcinoma4 sub
Primary Peritoneal Transitional Cell Carcinoma
Sarcomatoid Transitional Cell Carcinoma1 sub
Urothelial Carcinoma9 sub

96 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Data not yet available

No anatomical site linked yet.

Record

Identity

CancerIndex ID: CI-CAN-00001613
Entity type: Histology
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 4
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

734 / 253

Publications (all / 5y)

23,381 / 4,089

Evidence items

22

Genes / variants

410 / 23

Drugs (any / approved)

13 / 5

Genomic cohorts

24

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (5)

Carcinoma, Transitional Cellmesh_heading · MeSH
CARCINOMA, UROTHELIAL, MALIGNANTsynonym · NCIt
Cell Carcinoma, Transitionalsynonym · MeSH
Transitional Carcinomasynonym · NCIt
Transitional Cell Carcinomasynonym · CIViC

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials253countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #125 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials124countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #131 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items22countaccepted CIViC items · entity + descendantscivicComputedrank #140 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months568countPubMed records · stored query · 12-month windowpubmedComputedrank #134 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts24countopen GDC projects · entity + descendantsgdcComputedrank #54 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 18 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants